
Journal of Medicinal Chemistry p. 1174 - 1181 (1984)
Update date:2022-08-04
Topics:
Wissner
Sum
Schaub
Kohler
Goldstein
Analogues of platelet activating factor (PAF) in which the ether oxygen has been removed and in which the alkoxy chain at C1 has been replaced with a o-, p-, or m-alkylphenoxy group (30, 31, and 35, respectively) have been prepared. Compound 6 shows reduced platelet aggregation and hypotensive activity in comparison with C16 and C18 PAF. The results obtained for compounds 30, 31, and 35 indicate that the hypotensive and platelet aggregating responses are sensitive to structural modification of the ether chain. The ortho analogue 30 shows no platelet aggregating activity and only a weak hypotensive response. The para analogue 31 exhibits a moderate decrease in activity in both assays. The meta analogue 35 is the most active of the three.
View MoreWuhan Yitongtai Science and Technology Co.,Ltd.
Contact:+86-27-88933550
Address:27th Fl. Bldg. 1, Shuian International Mansion, Heping Ave, Wuhan, Hubei, China
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Shanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Nanjing Capatue Chemical Co., Ltd
Contact:+86-25-86371192 +86-025-85720158
Address:No.20 Jiangjun Avenue, Jiangning Economic & Technical Development Zone
Contact:+1 (647) 918 5848
Address:2343 BRIMLEY RD., Suite 250
Doi:10.1016/j.jcat.2021.02.030
(2021)Doi:10.1055/s-2006-942452
(2006)Doi:10.1016/j.tetlet.2008.04.132
(2008)Doi:10.1016/j.bmc.2006.10.012
(2007)Doi:10.1246/cl.2006.712
(2006)Doi:10.1021/jo01058a059
(1962)